MedPath

comparision of three doses of local anaesthetic Bupivacaine introduced into the spinal column of patients undergoing operation of the thigh and leg.

Phase 4
Not yet recruiting
Conditions
ASA 1 and 2 undergoing lower limb surgery
Registration Number
CTRI/2018/01/011593
Lead Sponsor
Ramapati Sanyal
Brief Summary

Spinal anaesthesia is  the anaesthesia of choice in adults undergoing lower limb surgery,provided there is no significant co-morbidity. But spinal anaesthesia can cause hypotension , bradycardia and prolonged immobilisation which can be harmful and distressing to the patient. The aim of the present study was to compare three different doses of bupivacaine  for lower limb surgery in sixty ASA grade 1 and 2 patients aged 18 to 80 yrs of age. The parameters used will be systolic, diastolic and mean blood pressure and pulse rate. The secondary parameters will be recession of sensory and motor block at 2 hours using two dermatomal recession and modified bromage scale.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

ASA 1 and 2 Undergoing lower limb surgery.

Exclusion Criteria
  • Patient refusal.
  • Anatomically distorted spine.
  • Spine surgery.
  • Surgery extending beyond 3 hrs.
  • Patients with perioperative complications.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in pulse systolic diastolic and mean blood pressure2 hours
Time to first analgesic requirement.2 hours
Secondary Outcome Measures
NameTimeMethod
Recession of sensory and motor block using two segment recession time and modified Bromage scale respectively.4 hours

Trial Locations

Locations (1)

KPC Medical College

🇮🇳

Kolkata, WEST BENGAL, India

KPC Medical College
🇮🇳Kolkata, WEST BENGAL, India
Ramapati Sanyal
Principal investigator
9830163182
sanyalramapati@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.